Back

RT @MPishvaian
#TumorBoardTuesday #GI23
Many of us have asked how do weIO efficacy
Seligmann, et al ran a nice study to see if local Tx ORR
23 HCC pts were Txed w/ SBRT or RFA and received durvatreme concurrently
But the ORR was 0%

I really thought this study was promising